Brazilian actress and influencer Evelin Camargo publicly revealed her recent diagnosis of a rare lymphoma-large cell anaplastic lymphoma (BIA-ALCL)-linked to her breast implants on Tuesday, February 3. Camargo shared her experience on social media after noticing a rapid change in breast size, prompting medical investigation and ultimately, a diagnosis that highlights potential long-term risks associated with cosmetic surgery. the actress is now sharing her story to raise awareness and encourage regular check-ups for those with breast implants.
On Tuesday, February 3, actress and influencer Evelin Camargo revealed she was diagnosed with a rare lymphoma linked to breast implants. She shared the news on social media after noticing a sudden change in one of her breasts and seeking specialized medical attention.
On Tuesday, February 3, actress Evelin Camargo announced she had been diagnosed with a rare cancer associated with breast implants. According to Camargo, the diagnosis came after she noticed a rapid increase in size in one of her breasts. She also discussed the risks associated with long-term use of silicone prostheses and emphasized the importance of ongoing medical monitoring.
“I thought this video would be the best way to do this and tell you what’s happening in our lives. And it’s very difficult to talk about this, but just over a week ago I was diagnosed with large cell anaplastic lymphoma caused by the silicone implant,” she said.
“It’s a lymphoma known as BIA-ALCL. It’s extremely rare, I had never heard of it, but it happened to me. So, just for you to understand how it happened: in 2019 I had plastic surgery to reduce my breasts, I had a very large breast. I had the reduction and put in a small silicone prosthesis, just to get the shape,” she added.
In late December, Evelin noticed that one of her breasts had increased in size. After seeking medical attention, the initial suspicion was a prosthesis rupture, a common possibility in patients with implants. “Those who have followed me before saw that I had a sudden increase in breast size, overnight, my left breast almost tripled in size. And I went to the hospital, I was very nervous, initially everyone thought it was a prosthesis rupture, that it had cracked. Then I had an MRI and we discovered that it wasn’t, that it was intact,” she explained.
According to the actress, the presence of fluid around the prosthesis, known as late seroma, drew the doctors’ attention. Evelin underwent a puncture to remove the fluid and specific laboratory tests. The diagnosis was confirmed after immunohistochemical analysis, which identified large cell anaplastic lymphoma associated with breast implants (BIA-ALCL). This diagnosis highlights the importance of being aware of potential complications related to cosmetic surgery.
The influencer explained that the cancer was confined to the capsule surrounding the prosthesis and that the recommended treatment was silicone removal. “The good news is that the treatment, in most cases, is removal of the prosthesis. I had a test on Saturday, which I was waiting for the result of to be able to come and talk to you, to know what the grade is, they call it staging. And thank God the test came out, and it’s really only in the prosthesis, so my treatment will be explant,” she said.
Evelin took the opportunity to warn her followers: “But I decided to record this for you, for you to understand what’s happening, but also as a warning, not to create a kind of terror like: ‘remove your prostheses, never put silicone prostheses again.’ But for you to get check-ups, to get ultrasounds.”
Rare Disease
Although it manifests in the breast, BIA-ALCL does not originate in breast tissue. Breno Gusmão, a member of the Medical Committee of the Brazilian Lymphoma and Leukemia Association (Abrale), detailed the disease to the g1 portal.
“Large cell anaplastic lymphoma associated with breast implants is a cancer of the lymphatic system. It does not originate in the breast, but ends up manifesting there, because the trigger is the presence of the prosthesis, which can cause chronic inflammation over time,” the specialist pointed out.
Classified as rare, BIA-ALCL has an estimated incidence of about one case per 30,000 women with breast implants. The numbers vary depending on factors such as the type of prosthesis, duration of use, and country analyzed. Understanding the risks associated with breast implants is crucial for informed patient care.
Watch the full statement:
Influencer discovers rare cancer after getting silicone: “Overnight”
🎥 @evelincamargo#vgnoticias #EvelinCamargo#WomensHealth#BreastImplant pic.twitter.com/fiUhda9Zh1
— VGN – Journalism with Credibility (@VGNoticias) February 4, 2026
Follow Hugo Gloss on Google News and stay up to date with our highlights
